Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Little Rock, Arkansas
  • +228 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Montgomery, Alabama
  • +444 more
Mar 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Hypertension, Diabetes, Type 2, Chronic Kidney Diseases Trial in Calgary (Community Health Navigator Program)

Recruiting
  • Hypertension
  • +6 more
  • Community Health Navigator Program
  • Calgary, Alberta, Canada
    Calgary West Central Primary Care Network
Sep 28, 2021

Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))

Completed
  • Coronary Arteriosclerosis
  • +4 more
  • Atorvastatin (Lipitor)
  • Mississauga, Ontario, Cameroon
  • +120 more
Feb 17, 2021

Erectile Dysfunction, Diabetes, Type 2 Trial in Canada, United States (sildenafil, )

Completed
  • Erectile Dysfunction
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +28 more
Jan 28, 2021

Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Chandler, Arizona
  • +66 more
Dec 16, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Tresiba® After Switching Basal Insulin inPopulation With Type 1

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Calgary, Alberta, Canada
  • +31 more
Dec 5, 2019

Prediction of Neuropathy in Type 1 Diabetes

Completed
  • Diabetic Polyneuropathy
  • +4 more
  • Exposure: Corneal nerve fibre morphology by the CCM Procedure
  • Ann Arbor, Michigan
  • +4 more
Nov 4, 2019

Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +300 more
Sep 18, 2019

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Canada (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Calgary, Alberta, Canada
  • +90 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone maleate/metformin HCl)

Completed
  • Diabetes Mellitus, Type 2
  • rosiglitazone maleate/metformin hydrochloride
  • Anniston, Alabama
  • +101 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +93 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin Pump (Medtronic Minimed Paradigm® VEO))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin Pump (Medtronic Minimed Paradigm® VEO)
  • Atlanta, Georgia
  • +35 more
Feb 6, 2018

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, glyburide, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +489 more
Nov 27, 2017

Type 2 Diabetes Mellitus inUsual Clinical Practice in Canada

Completed
  • Diabetes Mellitus, Type 2
  • No Intervention
  • Calgary, Alberta, Canada
  • +22 more
Oct 27, 2017

Diabetes, Type 2 Trial in Worldwide (Placebo matching with Saxagliptin, Metformin IR, Metformin XR)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo matching with Saxagliptin
  • +3 more
  • Los Angeles, California
  • +15 more
Mar 7, 2017

Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Long Beach, California
  • +330 more
Mar 21, 2017